Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Sharon, Marsh"'
Autor:
Montserrat Baiget, Howard L. McLeod, Robert Culverhouse, Laia Paré, Derek J. Van Booven, Taylor Maxwell, Sharon Marsh, Albert Altes, Eugenio Marcuello, Janelle M. Hoskins
Purpose: Irinotecan is an important drug for the treatment of solid tumors. Although genes involved in irinotecan pharmacokinetics have been shown to influence toxicity, there are no data on pharmacodynamic genes. CDC45L, NFKB1, PARP1, TDP1, and XRCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca6b0307e3727b72c7de423482c6183
https://doi.org/10.1158/1078-0432.c.6518170.v1
https://doi.org/10.1158/1078-0432.c.6518170.v1
Autor:
Montserrat Baiget, Howard L. McLeod, Robert Culverhouse, Laia Paré, Derek J. Van Booven, Taylor Maxwell, Sharon Marsh, Albert Altes, Eugenio Marcuello, Janelle M. Hoskins
Supplementary Data from Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aa2d898b1b5428790be895aa3cd9b69
https://doi.org/10.1158/1078-0432.22440958.v1
https://doi.org/10.1158/1078-0432.22440958.v1
Publikováno v:
Gastroenterology Research and Practice, Vol 2016 (2016)
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world, and it comprises a spectrum of hepatic abnormalities from simple hepatic steatosis to steatohepatitis, fibrosis, cirrhosis, and liver cancer. While the pa
Externí odkaz:
https://doaj.org/article/48ab680df2e2442591d6523428ffb626
Publikováno v:
Gastroenterology Research and Practice, Vol 2016 (2016)
Externí odkaz:
https://doaj.org/article/dd51499e8e1646f9866be1ce30adeefc
Autor:
Lorin Dodbiba, Nanjiao J. Ying, Rebecca Wong, Sharon Marsh, Daniel J. Renouf, Jiahua H. Che, Abul Kalam Azad, Qin Kuang, Lawson Eng, Jennifer J. Knox, Helen Mackay, Dangxiao X. Cheng, Xin Qiu, Sevtap Savas, Geoffrey Liu, Alvina Tse, Gail Darling, Olusola Olusesan Faluyi, Wei Xu, Qihuang H. Zhang
Publikováno v:
Cancer Medicine
Polymorphisms in miRNA and miRNA pathway genes have been previously associated with cancer risk and outcome, but have not been studied in esophageal adenocarcinoma outcomes. Here, we evaluate candidate miRNA pathway polymorphisms in esophageal adenoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d909f0bbd285abd1819a48bdbcb08d0a
https://doi.org/10.1002/cam4.989
https://doi.org/10.1002/cam4.989
Autor:
Sharon Marsh
Publikováno v:
Molecular Diagnostics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7d871a4994bdada4307f58a97e77741
https://doi.org/10.1201/9780429066504-12
https://doi.org/10.1201/9780429066504-12
Autor:
Bingshu E. Chen, Qin Kuang, Sharon Marsh, Zhuo Chen, Ming-Sound Tsao, Sevtap Savas, Abul Kalam Azad, Yonathan Brhane, Sinead Cuffe, Dangxiao Cheng, Xin Qiu, Scott A. Laurie, Penelope A. Bradbury, Geoffrey Liu, Xiaoping Qiu, Glenwood D. Goss, Wei Xu, Natasha B. Leighl, Lesley Seymour, Frances A. Shepherd
Publikováno v:
Cancer Epidemiology. 41:50-56
Background The drug transporter ABCC2 is upregulated in non-small cell lung cancer (NSCLC) and implicated in platinum resistance. We evaluated the association between germline polymorphisms in the ABCC2 gene and survival outcomes of platinum-treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19f349ef2f65c9875a151aef0617523c
https://doi.org/10.1016/j.canep.2015.12.012
https://doi.org/10.1016/j.canep.2015.12.012
Publikováno v:
Gastroenterology Research and Practice
Gastroenterology Research and Practice, Vol 2016 (2016)
Gastroenterology Research and Practice, Vol 2016 (2016)
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world, and it comprises a spectrum of hepatic abnormalities from simple hepatic steatosis to steatohepatitis, fibrosis, cirrhosis, and liver cancer. While the pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e3ff5fe69140d00a17e32dfe0f0299
https://doi.org/10.1155/2016/2862173
https://doi.org/10.1155/2016/2862173
Publikováno v:
Personalized medicine. 7(2)
There is a growing consensus that the first and most necessary step to improving the efficiency, cost–effectiveness and quality of healthcare systems can be achieved through the implementation of interoperable patient-centric electronic health reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::362ed12dd8efe3c514bc82568a09ae0d
https://pubmed.ncbi.nlm.nih.gov/29783324
https://pubmed.ncbi.nlm.nih.gov/29783324
Autor:
Tibor van Rooij, Sharon Marsh
Publikováno v:
Personalized medicine. 13(1)
eHealth is an umbrella term incorporating any area that combines healthcare and technology to improve efficiencies and reduce costs. The ultimate goal of eHealth is to rationalize treatment selection to improve patient safety and outcomes. Telemedici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa0bba93ea2626ecac8343f82ea893a
https://pubmed.ncbi.nlm.nih.gov/29749870
https://pubmed.ncbi.nlm.nih.gov/29749870